SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
-4.26%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$642M
AUM Growth
+$642M
(-1.3%)
Cap. Flow
+$70.9M
Cap. Flow
% of AUM
11.04%
Top 10 Holdings %
Top 10 Hldgs %
47.56%
Holding
90
New
25
Increased
18
Reduced
19
Closed
18
Top Buys
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$28.8M |
| 2 |
United Therapeutics
UTHR
|
$18.8M |
| 3 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$12.7M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$10.4M |
| 5 |
Organogenesis Holdings
ORGO
|
$9.11M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$27.9M |
| 2 |
The Beauty Health Co
SKIN
|
$19M |
| 3 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$10.6M |
| 4 |
NovoCure
NVCR
|
$8.33M |
| 5 |
BioAtla
BCAB
|
$8.21M |
Sector Composition
| 1 | Healthcare | 91.89% |
| 2 | Financials | 1.01% |
| 3 | Consumer Staples | 0.82% |
| 4 | Real Estate | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Corcept Therapeutics
CORT
$7.35B
| $3.05M | 0.48% | +155,000 | New | +$3.05M |
|
|
ARYD
52
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $3.02M | 0.47% | 300,000 | – | – |
|
|
CDMO
53
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.91M | 0.45% | +135,000 | New | +$2.91M |
|
54
Dyne Therapeutics
DYN
$1.92B
| $2.9M | 0.45% | 178,360 | – | – |
|
|
ZGNX
55
DELISTED
Zogenix, Inc.
ZGNX
| $2.6M | 0.4% | +171,000 | New | +$2.6M |
|
56
Axogen
AXGN
$743M
| $2.5M | 0.39% | 158,140 | – | – |
|
57
Lyra Therapeutics
LYRA
$11.5M
| $1.97M | 0.31% | 215,576 +32,500 | +18% | +$297K |
|
58
Celcuity
CELC
$2.17B
| $1.51M | 0.23% | 83,688 -81,136 | -49% | -$1.46M |
|
|
EIGR
59
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.43M | 0.22% | 213,519 | – | – |
|
60
Bioventus
BVS
$495M
| $1.34M | 0.21% | +94,602 | New | +$1.34M |
|
61
CytomX Therapeutics
CTMX
$336M
| $1.33M | 0.21% | +261,050 | New | +$1.33M |
|
62
Astria Therapeutics
ATXS
$349M
| $994K | 0.15% | 112,499 -662,501 | -85% | -$5.85M |
|
63
Editas Medicine
EDIT
$231M
| $965K | 0.15% | 23,500 -72,100 | -75% | -$2.96M |
|
|
NGM
64
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $862K | 0.13% | +41,000 | New | +$862K |
|
65
Procept Biorobotics
PRCT
$2.23B
| $763K | 0.12% | +20,000 | New | +$763K |
|
|
CUTR
66
DELISTED
Cutera, Inc.
CUTR
| $675K | 0.11% | 14,480 -88,500 | -86% | -$4.13M |
|
67
Beam Therapeutics
BEAM
$1.66B
| $670K | 0.1% | 7,700 -14,400 | -65% | -$1.25M |
|
68
Rafael Holdings
RFL
$51.6M
| $668K | 0.1% | 21,742 -15,000 | -41% | -$461K |
|
69
Monte Rosa Therapeutics
GLUE
$296M
| $557K | 0.09% | 25,000 -50,000 | -67% | -$1.11M |
|
70
Edgewise Therapeutics
EWTX
$1.51B
| $520K | 0.08% | 31,300 | – | – |
|
71
Dianthus Therapeutics
DNTH
$759M
| – | – | -90,000 | Closed | -$880K |
|
72
DexCom
DXCM
$29.5B
| – | – | -5,884 | Closed | -$2.51M |
|
73
Establishment Labs
ESTA
$1.2B
| – | – | -26,568 | Closed | -$2.32M |
|
74
Guardant Health
GH
$8.41B
| – | – | -17,500 | Closed | -$2.17M |
|
75
Galecto
GLTO
$4.21M
| – | – | -538,152 | Closed | -$2.72M |
|